BIOLINERX
RSS
RSS
| Careers | Contact Us
search

Investor relations home

BioLineRx is a publicly-traded (NASDAQ/TASE: BLRX), clinical-stage biopharmaceutical company based in Modi'in, Israel, dedicated to identifying, in-licensing and developing promising therapeutic candidates. The Company in-licenses novel compounds primarily from academic institutions and biotech companies based in Israel, develops them through pre-clinical and/or clinical stages, and then partners with pharmaceutical companies for advanced clinical development and/... More >>

Therapeutic pipeline
Title
Download Documentation Pipeline
Upcoming events
DateTitle
06/03/16
BioLineRx will attend the 2016 ASCO Annual Meeting in Chicago, Illinois, June 3-7, 2016
06/06/16
BioLineRx to attend the 2016 BIO International Convention in San Francisco, California
06/09/16
BioLineRx will present at the 21st Congress of EHA from June 9-12 in Copenhagen, Denmark
06/20/16
BioLineRx to present at the JMP Securities Healthcare Conference June 20-21, 2016
What's new
DateTitle
03/14/16
Download Documentation BioLineRx Company presentation
Get help downloading or viewing the above file types